Atlas Trials

[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease

Clinical trial NCT06141356 · UNKNOWN

Trial details

NCT number
NCT06141356
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Alzheimer's Disease
Start date
2023-01-30
Primary completion
2024-12-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.